#NewAseBioMember | “AseBio is an important industry association in Spain, representing the... 16/04/2024 Healthcare Digitalization Corporate Meet Owkin, our new member. We talked to its Francisco Miguel Torres, Partnerships Director, Southern Europe. AseBio - OWKIN
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Antibiotic resistance Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally... AseBio
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 We consider that improvements have been made regarding the original proposal, but these continue to be insufficient for... AseBio
Webinar: Preparing for IVDR Clinical Performance Studies Online Del 30/04/2024 17:00 to 30/04/2024 18:00 Healthcare Access to innovation In vitro diagnostics Personalized medicine The webinar will focu on the critical aspects of designing and conducting In Vitro Diagnostic (IVD) performance studies...
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications aimed at alleviating... AseBio
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Approximately 10,000 new cases of Parkinson's are detected each year in Spain, with a total figure exceeding 150,000... AseBio
World Orphan Drug Congress Europe Barcelona Spain Del 22/10/2024 to 25/10/2024 Healthcare Drug discovery International Strategy, Advocacy & Partnering for The Global Orphan Drug Industry.
#NewAseBioMember | “AseBio is the perfect platform for company collaboration, research syn... 09/04/2024 Healthcare Corporate Meet Copal Scientific, our new member. We talked to its Mercedes Iriarte Cela, CEO. AseBio
#NewAseBioMember | “AseBio represents a platform within the bioindustry ecosystem” 09/04/2024 Healthcare Corporate Meet Spinally Medical, our new member. We talked to its Carles García-Vitoria, Co-fundador & Chief Scientific Officer. AseBio
ORYZON announces U.S. FDA clearance of CTEP-CRADA Phase I/II clinical trial sponsored by N... 08/04/2024 Healthcare Access to innovation In combination with either atezolizumab or durvalumab. Partners - Oryzon Genomics
